Prevention of Donor to Recipient Transmission of HCV in Stem Cell Transplantation: Some Issues

Prevention of Donor to Recipient Transmission of HCV in Stem Cell Transplantation: Some Issues

[1]  Keith Abrams,et al.  Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies , 2007, The American Journal of Gastroenterology.

[2]  P. Hari,et al.  Suppressive Anti-HCV Therapy for Prevention of Donor to Recipient Transmission in Stem Cell Transplantation , 2007, The American Journal of Gastroenterology.

[3]  Y. Yamaji,et al.  A Randomized Controlled Trial Evaluating the Usefulness of a Transparent Hood Attached to the Tip of the Colonoscope , 2007, The American Journal of Gastroenterology.

[4]  J. Bond,et al.  Should Patients With Anemia and Low Normal or Normal Serum Ferritin Undergo Colonoscopy? , 2007, The American Journal of Gastroenterology.

[5]  Ming‐Lung Yu,et al.  Outcome of Chronic Hepatitis C Patients who Required Early Termination of Pegylated Interferon-α plus Ribavirin Combination Therapy , 2006, Antiviral therapy.

[6]  P. Chandrasoma.  Columnar Lined Esophagus: What it is and what it tells us , 2006, European Surgery.

[7]  J. Sung,et al.  Improved Colonoscopy Success Rate with a Distally Attached Mucosectomy Cap , 2006, Endoscopy.

[8]  M. Feith,et al.  Preferred location for the development of esophageal adenocarcinoma within a segment of intestinal metaplasia , 2006, Surgical Endoscopy And Other Interventional Techniques.

[9]  H. Bonkovsky.  Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). , 2006, Annals of internal medicine.

[10]  R. Gloro,et al.  Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. , 2005, European journal of gastroenterology & hepatology.

[11]  S. Pol,et al.  The Impact of Haematopoietic Growth Factors on the Management and Efficacy of Antiviral Treatment in Patients with Hepatitis C Virus , 2005, Antiviral therapy.

[12]  P. Chandrasoma,et al.  Controversies of the cardiac mucosa and Barrett's oesophagus , 2005, Histopathology.

[13]  T. Stevens,et al.  Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. , 2005, Annals of internal medicine.

[14]  A. Mitchell,et al.  Recent trends in use of herbal and other natural products. , 2005, Archives of internal medicine.

[15]  C. Lightdale,et al.  EUS-guided trucut needle biopsies in patients with solid pancreatic masses: a prospective study. , 2004, Gastrointestinal endoscopy.

[16]  J. Peters,et al.  Histologic Classification of Patients Based on Mapping Biopsies of the Gastroesophageal Junction , 2003, The American journal of surgical pathology.

[17]  D. Binion,et al.  Case report: magnetic resonance imaging in the diagnosis of epidural abscess complicating perirectal fistulizing Crohn's disease. , 2003, Inflammatory Bowel Diseases.

[18]  Rebecca S. Graves,et al.  Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. , 2002 .

[19]  M. Levy,et al.  Initial experience with EUS-guided trucut needle biopsies of perigastric organs. , 2002, Gastrointestinal endoscopy.

[20]  G. Jenkins,et al.  Comparative Evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR Version 2.0 Assays for Quantification of Hepatitis C Virus RNA in Serum , 2002, Journal of Clinical Microbiology.

[21]  N. Kröger,et al.  Dose and Schedule Effect of G-GSF for Stem Cell Mobilization in Healthy Donors for Allogeneic Transplantation , 2002, Leukemia & lymphoma.

[22]  T. Demeester,et al.  Distribution and Significance of Epithelial Types in Columnar-Lined Esophagus , 2001, The American journal of surgical pathology.

[23]  Ming‐Lung Yu,et al.  Clinical Evaluation of the Automated COBAS AMPLICOR HCV MONITOR Test Version 2.0 for Quantifying Serum Hepatitis C Virus RNA and Comparison to the Quantiplex HCV Version 2.0 Test , 2000, Journal of Clinical Microbiology.

[24]  G. Dafnis.  Technical Considerations and Patient Comfort in Total Colonoscopy with and without a Transparent Cap: Initial Experiences from a Pilot Study , 2000, Endoscopy.

[25]  J. Sleigh,et al.  Pneumocephalus resulting from an inflammatory neuro-enteric fistula: a case report. , 1998, Australian and New Zealand Journal of Surgery.

[26]  K. Okazaki,et al.  Efficacy of Total Colonoscopy with a Transparent Cap in Comparison with Colonoscopy without the Cap , 1998, Endoscopy.

[27]  H. Inoue,et al.  Feasibility of the transparent cap-fitted colonoscope for screening and mucosal resection , 1997, Diseases of the colon and rectum.

[28]  R. G. Cornell,et al.  Integrating Stratum-specific Likelihood Ratios with the Analysis of ROC Curves , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.

[29]  O. Hochberger,et al.  Crohn's Disease Penetrating into the Spinal Canal , 1989, Acta paediatrica Scandinavica.

[30]  William H. Barker,et al.  CLINICAL EPIDEMIOLOGY: THE ESSENTIALS. , 1984 .

[31]  A. Lynn,et al.  Pneumocephalus: an unusual presentation of a persistent neurenteric fistula. , 1978, The Journal of pediatrics.

[32]  S. Stryker,et al.  Meningitis and epidural abscess associated with fistulizing Crohn's disease. , 2004, Digestive diseases and sciences.

[33]  J. Clain,et al.  Preliminary experience with an EUS-guided trucut biopsy needle compared with EUS-guided FNA. , 2003, Gastrointestinal endoscopy.

[34]  R. Sampliner,et al.  Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus , 2002, American Journal of Gastroenterology.

[35]  A. Zajko,et al.  Transjugular liver biopsy: a prospective study in 43 patients with the Quick-Core biopsy needle. , 1996, Journal of vascular and interventional radiology : JVIR.